Cargando…

An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy

Recently, near-infrared (NIR) light-based photothermal therapy (PTT) has been widely applied in cancer treatment. However, in most cases, the tissue penetration depth of NIR light is not sufficient and thus photothermal therapy is unable to completely eradicate deep, seated tumors inevitably leading...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling, Yang, Suleixin, Song, Linjiang, Zeng, Yan, He, Tao, Wang, Ning, Yu, Chuan, Yin, Tao, Liu, Li, Wei, Xiawei, Wu, Qinjie, Wei, Yuquan, Yang, Li, Gong, Changyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771099/
https://www.ncbi.nlm.nih.gov/pubmed/29344312
http://dx.doi.org/10.7150/thno.19826
_version_ 1783293199498870784
author Li, Ling
Yang, Suleixin
Song, Linjiang
Zeng, Yan
He, Tao
Wang, Ning
Yu, Chuan
Yin, Tao
Liu, Li
Wei, Xiawei
Wu, Qinjie
Wei, Yuquan
Yang, Li
Gong, Changyang
author_facet Li, Ling
Yang, Suleixin
Song, Linjiang
Zeng, Yan
He, Tao
Wang, Ning
Yu, Chuan
Yin, Tao
Liu, Li
Wei, Xiawei
Wu, Qinjie
Wei, Yuquan
Yang, Li
Gong, Changyang
author_sort Li, Ling
collection PubMed
description Recently, near-infrared (NIR) light-based photothermal therapy (PTT) has been widely applied in cancer treatment. However, in most cases, the tissue penetration depth of NIR light is not sufficient and thus photothermal therapy is unable to completely eradicate deep, seated tumors inevitably leading to recurrence of the tumor. Due to this significant limitation of NIR, improved therapeutic strategies are urgently needed. Methods: We developed an endogenous vaccine based on a novel nanoparticle platform for combinatorial photothermal ablation and immunotherapy. The design was based on fluorophore-loaded liposomes (IR-7-lipo) coated with a multivalent immunoadjuvant (HA-CpG). In vitro PTT potency was assessed in cells by LIVE/DEAD and Annexin V-FITC/PI assays. The effect on bone marrow-derived dendritic cells (BMDC) maturation and antigen presentation was evaluated by flow cytometry (FCM) with specific antibodies. After treatment, the immune cell populations in tumor micro-environment and the cytokines in the serum were detected by FCM and Elisa assay, respectively. Finally, the therapeutic outcome was investigated in an animal model. Results: Upon irradiation with 808 nm laser, IR-7-lipo induced tumor cell necrosis and released tumor-associated antigens, while the multivalent immunoadjuvant improved the expression of co-stimulatory molecules on BMDC and promoted antigen presentation. The combination therapy of PTT and immunotherapy regulated the tumor micro-environment, decreased immunosuppression, and potentiated host antitumor immunity. Most significantly, due to an enhanced antitumor immune response, combined photothermal immunotherapy was effective in eradicating tumors in mice and inhibiting tumor metastasis. Conclusion: This endogenous vaccination strategy based on synergistic photothermal and immunotherapy may provide a potentially effective approach for treatment of cancers, especially those difficult to be surgically removed.
format Online
Article
Text
id pubmed-5771099
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-57710992018-01-17 An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy Li, Ling Yang, Suleixin Song, Linjiang Zeng, Yan He, Tao Wang, Ning Yu, Chuan Yin, Tao Liu, Li Wei, Xiawei Wu, Qinjie Wei, Yuquan Yang, Li Gong, Changyang Theranostics Research Paper Recently, near-infrared (NIR) light-based photothermal therapy (PTT) has been widely applied in cancer treatment. However, in most cases, the tissue penetration depth of NIR light is not sufficient and thus photothermal therapy is unable to completely eradicate deep, seated tumors inevitably leading to recurrence of the tumor. Due to this significant limitation of NIR, improved therapeutic strategies are urgently needed. Methods: We developed an endogenous vaccine based on a novel nanoparticle platform for combinatorial photothermal ablation and immunotherapy. The design was based on fluorophore-loaded liposomes (IR-7-lipo) coated with a multivalent immunoadjuvant (HA-CpG). In vitro PTT potency was assessed in cells by LIVE/DEAD and Annexin V-FITC/PI assays. The effect on bone marrow-derived dendritic cells (BMDC) maturation and antigen presentation was evaluated by flow cytometry (FCM) with specific antibodies. After treatment, the immune cell populations in tumor micro-environment and the cytokines in the serum were detected by FCM and Elisa assay, respectively. Finally, the therapeutic outcome was investigated in an animal model. Results: Upon irradiation with 808 nm laser, IR-7-lipo induced tumor cell necrosis and released tumor-associated antigens, while the multivalent immunoadjuvant improved the expression of co-stimulatory molecules on BMDC and promoted antigen presentation. The combination therapy of PTT and immunotherapy regulated the tumor micro-environment, decreased immunosuppression, and potentiated host antitumor immunity. Most significantly, due to an enhanced antitumor immune response, combined photothermal immunotherapy was effective in eradicating tumors in mice and inhibiting tumor metastasis. Conclusion: This endogenous vaccination strategy based on synergistic photothermal and immunotherapy may provide a potentially effective approach for treatment of cancers, especially those difficult to be surgically removed. Ivyspring International Publisher 2018-01-01 /pmc/articles/PMC5771099/ /pubmed/29344312 http://dx.doi.org/10.7150/thno.19826 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Li, Ling
Yang, Suleixin
Song, Linjiang
Zeng, Yan
He, Tao
Wang, Ning
Yu, Chuan
Yin, Tao
Liu, Li
Wei, Xiawei
Wu, Qinjie
Wei, Yuquan
Yang, Li
Gong, Changyang
An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
title An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
title_full An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
title_fullStr An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
title_full_unstemmed An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
title_short An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy
title_sort endogenous vaccine based on fluorophores and multivalent immunoadjuvants regulates tumor micro-environment for synergistic photothermal and immunotherapy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771099/
https://www.ncbi.nlm.nih.gov/pubmed/29344312
http://dx.doi.org/10.7150/thno.19826
work_keys_str_mv AT liling anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yangsuleixin anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT songlinjiang anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT zengyan anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT hetao anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT wangning anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yuchuan anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yintao anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT liuli anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT weixiawei anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT wuqinjie anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT weiyuquan anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yangli anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT gongchangyang anendogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT liling endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yangsuleixin endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT songlinjiang endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT zengyan endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT hetao endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT wangning endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yuchuan endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yintao endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT liuli endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT weixiawei endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT wuqinjie endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT weiyuquan endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT yangli endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy
AT gongchangyang endogenousvaccinebasedonfluorophoresandmultivalentimmunoadjuvantsregulatestumormicroenvironmentforsynergisticphotothermalandimmunotherapy